SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-001789
Filing Date
2004-05-05
Accepted
2004-05-05 17:26:16
Documents
3
Period of Report
2004-05-05
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. w97074e8vk.htm 8-K 5569
2 PRESS RELEASE DATED MAY 5, 2004 w97074exv99w1.htm EX-99.1 28564
3 GRAPHIC w97074w97074.gif GRAPHIC 4056
  Complete submission text file 0000950133-04-001789.txt   40035
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 04782592
SIC: 2836 Biological Products, (No Diagnostic Substances)